Allergan, is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live good life.

Employee Rating

3.4More
TypePublic
HQDublin, IE
Founded1948
Size (employees)17,800 (est)+7%
Websiteallergan.com
Allergan was founded in 1948 and is headquartered in Dublin, IE
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Allergan

Brenton L. Saunders

Brenton L. Saunders

Chairman, President and CEO, Allergan
William Meury

William Meury

EVP & Chief Commercial Officer
Matt Walsh

Matt Walsh

EVP & Chief Financial Officer
A. Robert D. Bailey

A. Robert D. Bailey

EVP & Chief Legal Officer and Corporate Secretary
Karen L. Ling

Karen L. Ling

EVP & Chief Human Resources Officer
C. David Nicholson

C. David Nicholson

EVP & Chief R&D Officer
Show more

Allergan Office Locations

Allergan has offices in Parsippany-Troy Hills and Dublin
Parsippany-Troy Hills, US
400 Interpace Pkwy
Show all (2)
Report incorrect company information

Allergan Financials and Metrics

Allergan Revenue

Allergan's revenue was reported to be $15.07 b in FY, 2015
USD

Market capitalization (9-Nov-2018)

55.8b

Closing stock price (9-Nov-2018)

165.5
Allergan's current market capitalization is $55.8 b.
Annual
USDFY, 2015

Revenue

15.1b

Sales and marketing expense

2.9b

Operating expense total

2.9b
Quarterly
USDQ2, 2015

Revenue

5.8b

Sales and marketing expense

981.0m

Operating expense total

981.0m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

329.0m4.9b1.1b1.7b

Accounts Receivable

914.5m2.5b2.9b

Inventories

296.0m718.0m

Current Assets

6.9b
Quarterly
USDQ3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018Q3, 2018

Accounts Receivable

2.5b

Inventories

2.8b

PP&E

2.9b

Goodwill

46.7b
Annual
USDFY, 2013FY, 2014FY, 2015

Net Income

988.7m1.5b

Depreciation and Amortization

202.0m248.1m

Inventories

(27.0m)(44.0m)

Accounts Payable

37.4m1.9m
Quarterly
USDQ1, 2014Q2, 2015Q2, 2016Q3, 2017

Cash From Operating Activities

2.6b

Purchases of PP&E

(234.0m)

Dividends Paid

(917.0m)

Cash From Financing Activities

(368.0m)33.8b
Show all financial metrics

Allergan Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
BontiSeptember 14, 2018$195 m
ElastagenFebruary 07, 2018$95 m
ZELTIQ Aesthetics (CoolSculpting)February 15, 2017$2.48 b
Report incorrect company information

Allergan Online and Social Media Presence

Embed Graph
Report incorrect company information

Allergan News and Updates

Allergan says offers undervalue business units for sale, shares fall

(Reuters) - Allergan Plc on Tuesday expressed disappointment in early offers from potential buyers for business units it has been trying to sell, and its shares fell more than 6 percent.

Allergan CEO disappointed with early buyer interest in business units

Allergan Plc's Chief Executive Officer Brent Saunders said on Tuesday early buyer interest in its women's health and infectious diseases business units was below the price of what he believes the businesses are valued.

Allergan reports Q3 beats alongside net loss

Allergan PLC reported third-quarter profit and revenue beats early Tuesday alongside a net loss for the quarter, and raised its 2018 guidance. The company reported a loss of $37.9 million, or a loss of 11 cents per share, after a loss of $4.03 billion, or a loss of $12.07 per share in the year-earl…

Allergan narrows loss in latest quarter but widens full-year loss forecast

Botox maker Allergan Plc said Tuesday it had a net loss of $37.9 million, or 11 cents a share, in the third quarter, narrower than the loss of $4.025 billion, or $12.07 a share, posted in the year-earlier quarter. The company booked impairment charges on some of its drugs in 2017. Adjusted per-shar…

Allergan Declares Fourth Quarter 2018 Cash Dividend of $0.72 Per Ordinary Share

DUBLIN, Oct. 26, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.72 per ordinary share for the fourth quarter of 2018. The dividend will be paid on December 14, 2018 to shareholders of record at the close of...

Facial Aesthetics 2018 Global Market Key Players – Allergan, Anika Therapeutics, Contura, Ipsen, Merz Pharma – Analysis and Forecast to 2022

WiseGuyRerports.com Presents “Global Soft Ice Cream Machines Market Report 2018” New Document to its Studies Database. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more
Report incorrect company information

Allergan Blogs

Allergan to Present at Credit Suisse 27th Annual Healthcare Conference

DUBLIN, Nov. 5, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that Chief Commercial Officer William Meury will present at the Credit Suisse 27...

Allergan and The Allergan Foundation Support U.S. Veterans With "Heroes MAKE America" Sponsorship

- The Manufacturing Institute's Career Skills Program Connects Veterans with Potential Manufacturing Jobs - - Sponsorship includes $125,000 Grant for "Heroes MAKE America" Expansion at Fort Hood in T...

Allergan To Present Data From 13 Abstracts At The 2018 American Society For Dermatologic Surgery Meeting In Phoenix

DUBLIN, Oct. 11, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, announced today that it will present 13 abstracts at the annual American Society for Dermatolog...

Allergan Presents New Research at the American College of Gastroenterology Annual Scientific Meeting (ACG 2018)

DUBLIN, Oct. 8, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced it will present data from its gastroenterology portfolio at the American College...

Allergan Launches New JUVÉDERM® IT Campaign Designed To Reach The Next Generation Of Consumers

Bigger, bolder JUVÉDERM® campaign seeks to make JUVÉDERM® a household name for consumers DUBLIN, Oct. 3, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today the launch of a new JUVÉDERM...

Allergan to Report Third Quarter 2018 Earnings and Host Conference Call and Webcast

DUBLIN, Oct. 1, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it intends to release third quarter 2018 financial results on Tuesday, October 30, 2018, prior to the open of U.S. fi...
Show more

Allergan Company Life and Culture

Report incorrect company information

Allergan Frequently Asked Questions

  • When was Allergan founded?

    Allergan was founded in 1948.

  • Who are Allergan key executives?

    Allergan's key executives are Brenton L. Saunders, William Meury and Matt Walsh.

  • How many employees does Allergan have?

    Allergan has 17,800 employees.

  • Who are Allergan competitors?

    Competitors of Allergan include Roche, XOMA and Cantabio Pharmaceuticals.

  • Where are Allergan offices?

    Allergan has offices in Parsippany-Troy Hills and Dublin.

  • How many offices does Allergan have?

    Allergan has 2 offices.